AlphaCore Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
34,158
+12,144
+55% +$1.11M 0.06% 249
2026
Q1
$2.26M Sell
22,014
-6,123
-22% -$691K 0.05% 240
2025
Q4
$3.53M Buy
28,137
+17,224
+158% +$2.19M 0.08% 200
2025
Q3
$1.46M Buy
10,913
+3,799
+53% +$499K 0.05% 230
2025
Q2
$968K Buy
7,114
+2,713
+62% +$358K 0.04% 264
2025
Q1
$584K Buy
+4,401
New +$560K 0.05% 242
2024
Q4
Sell
-1,904
Closed -$217K 259
2024
Q3
$217K Buy
+1,904
New +$209K 0.05% 186
2024
Q2
Sell
-2,844
Closed -$323K 226
2024
Q1
$323K Buy
2,844
+184
+7% +$21.1K 0.09% 121
2023
Q4
$293K Sell
2,660
-644
-19% -$64.3K 0.04% 192
2023
Q3
$320K Buy
+3,304
New +$347K 0.05% 178
2020
Q2
Sell
-419
Closed -$33K 72
2020
Q1
$33K Buy
+419
New +$35K 0.03% 127

Other funds holding ABT

AlphaCore Capital's ABT Position: Q2 2026 in Review

AlphaCore Capital increased its Abbott (ABT) stake by 55% in Q2 2026, buying an estimated $1.11M and bringing the position to 34,158 shares worth $3.1M. The position accounts for 0.06% of the portfolio, ranked #249.

AlphaCore Capital first reported a position in ABT in Q1 2020 and has held it in 11 quarters since. The position peaked at $3.53M in Q4 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • AlphaCore Capital held 34,158 shares of Abbott worth $3.1M as of Q2 2026.
  • AlphaCore Capital bought 12,144 Abbott shares in Q2 2026, an estimated $1.11M.
  • Abbott made up 0.06% of AlphaCore Capital's portfolio in Q2 2026, its #249 holding.
  • AlphaCore Capital first reported a position in Abbott in Q1 2020 and has held it in 11 quarters since.
  • AlphaCore Capital's Abbott position peaked at $3.53M in Q4 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.